Daniel Loeb
Daniel S. Loeb runs $4.5 billion New York-based hedge fund Third Point LLC, which he founded in 1995. Loeb is known for his scathing letters to companies, in which he often criticizes management and pushes for changes. He has focused on investments in biotech and oil/gas, among other areas. Loeb is considered an activist investor, but also has many passive investments.
Loeb graduated from Columbia University.
Loeb in known for collecting art, enjoying yoga and living large. Loeb spent $45 million for a 10,000 sq penthouse at 15 Central Park West.
-
Loeb's Third Point LLC 13F Shows New Stake Axalta (AXTA), Morgan Stanley (MS), Liquidates T-Mobile (TMUS), Lowers eBay (EBAY) ...
-
Loeb's Third Point 13F Show Liquidates SunEdison (SUNE), Builds New Stake in Avago (AVGO), Danaher (DHR) (more...)
-
Loeb's Third Point 13F Shows New Stake in Nokia (NOK), Ziopharm (ZIOP), Molson Coors (TAP), T-Mobile (TMUS), Sells Maxim (MXIM), Precision Castparts (PCP), (more ...)
-
Loeb's Third Point Cuts Amgen (AMGN), eBay (EBAY), Adds to Delta (DAL), Actavis (ACT) Stakes
-
Loeb's Third Point LLC Shows news Stakes in Actavis (ACT), American Airlines (AAL), Citrix (CRX), Verizon (VZ); Liquidates (YHOO) (AAPL) (BBRY)
-
Loeb's Third Point Enters BlackBerry (BBRY), Dow Chemical (DOW), Hertz (HTZ)
-
Loeb's Third Point Enters Walt Disney (DIS); Boosts Sothebys (BID), Sells SPDR Gold (GLD)
-
Loeb's Third Point LLC Enters Anadarko (APC), NXP Semi (NXPI), Tiffany & Co. (TIF); Exits Herbalife (HLF), Morgan Stanley (MS)
-
Loeb's Third Point New Stake in (DG) (HLF) (MS) (NWSA) (TSO); Cuts (AIG), Liquidates (AAPL)
-
Loeb's Third Point LLC Hedge Fund Releases Q3 2011 13F
-
Loeb's Third Point Shows New Stake in Freeport (FCX), Mosaic (MOS), Raised Stake in Big Lots (BIG), Liquidated Apple (AAPL), CBS (CBS)
-
Loeb's Third Point Hedge Fund Gets Out of Citigroup (C), Shows New Stakes in CBS (CBS) and eBay (EBAY) Among Others
-
Loeb's Third Point Jumps Into BofA, Citi, Comcast, Yahoo!, Sells Out of Amedisys, Northern Trust (BAC) (C) (YHOO) (AMED)

